New NPY research & Panion in Feminvest event 6 March in Malmö
Panion’s CEO Anja Holm will present the company’s plans, progress and outlook at the Feminvest investors event in Malmö on the 6.th of March 2018, 17.00 – 20.30. New as well as existing shareholders can ask questions and satisfy their interest in the company’s potential. http://www.feminvest.nu “I look forward to the event”, says Anja Holm, “where I will also tell a bit more about the supportive new study from Australia, which was recently published.” This study is independent of Panion’s and CombiGene’s research, but it uses the same neuropeptide NPY as a treatment in a rat model of